ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269756 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269756; 2) Community: the network communities that were significantly associated with the response to NSC 269756; 3) Molecule: the relationships between components within communities and NSC 269756; 4) MDR: the compounds that were significantly associated with the NSC 269756.

NSC Compound Enrichment Correlation
NSC 670313 Null 0.0178844438004195 -0.028496973
NSC 676372 Null 0.0178844438004195 0.19911808
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0178844438004195 0.14283098
NSC 677776 Null 0.0178844438004195 -0.014827915
NSC 678355 L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 0.0178844438004195 0.21836848
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0178844438004195 0.26602028
NSC 679800 Null 0.0178844438004195 0.067563854
NSC 681239 Bortezomib 0.0178844438004195 0.50049296
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0178844438004195 -0.092426054
NSC 690270 ANTINEOPLASTIC-690270 0.0178844438004195 0.37852348
Total:149  Current:79    [First] [Prev] [Next] [Last]